The computational characterization approach found that MHC-I subunit human leukocyte antigen (HLA) genes are significantly methylated in IDH-mutant glioma cell lines compared with IDH-wildtype GBM lines, suggesting that the MHC-I-mediated antigen presentation is impaired in IDH-mutant gliomas [110]. This evidence concerns the gene IDH2 and central nervous system cancer.